Viral inactivation of fresh frozen plasma

British Journal of Haematology

Volumn 109, Issue 4, 2000, Pages 680-693

  Pamphilon, Derwood ^a  

^a NHS BLOOD AND TRANSPLANT   (United Kingdom)

Author keywords

Blood safety; Methylene blue; Plasma; Solvent detergent; Viral inactivation

Indexed keywords

4' AMINOMETHYL 4,5',8 TRIMETHYLPSORALEN; DETERGENT; FRESH FROZEN PLASMA; METHYLENE BLUE; PSORALEN; SOLVENT; TRIBUTYL PHOSPHATE; TRIMETHYLPSORALEN; TRIOXYSALEN; TRITON X 100;

BACTERICIDAL ACTIVITY; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; CLINICAL TRIAL; COST BENEFIT ANALYSIS; CRYOPRECIPITATE; CYTOKINE PRODUCTION; DRUG ACTIVITY; GENOTOXICITY; GRAFT VERSUS HOST REACTION; HEART SURGERY; HUMAN; LIVER DISEASE; METHODOLOGY; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; THROMBOTIC THROMBOCYTOPENIC PURPURA; ULTRAVIOLET A RADIATION; VIRUS INACTIVATION; VIRUS INFECTION; VIRUS TRANSMISSION;

BLOOD TRANSFUSION; HUMANS; METHYLENE BLUE; PLASMA; PUVA THERAPY; VIREMIA; VIRUSES;

EID: 0033867721     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.02019.x     Document Type: Review

References (88)

1. Abe, H. & Wagner, S. (1995) Analysis of viral DNA, protein and envelope damage after methylene blue, phthalocyanine derivative or merocyanine 540 photosensitization. Photochemistry and Photobiology, 61, 402-409.
2. Alfonso, R., Lin, C., Dupuis, K., Corten, L., Reames, A., Londe, H., Chen, C., Yip, J., Cook, D., Smyers, J., Clarke, S., Wages, D., Narayan, D., Hei, D., Wiesehahn, G. & Corash, L. (1996) Inactivation of viruses with preservation of coagulation function in fresh frozen plasma (Abstract). Blood, 88, 526a.
3. AuBuchon, J.P. & Birkmeyer, J.D. (1994) Safety and cost-effectiveness of solvent-detergent-treated plasma. Journal of the American Medical Association, 272, 1210-1214.
4. AuBuchon, J.P., Pichard, C., Herschel, L., O'Connor, J.L. & Lee, E. (1998) Removal of methylene blue from plasma via an adsorbent filter. Vox Sanguinis, 74, 1-6.
5. Bachmann, B., Knüver-Hopf, J., Lambrecht, B. & Mohr, H. (1995) Target structures for HIV-1 inactivation by methylene blue and light. Journal of Medical Virology, 47, 172-178.
6. Baudoux, E., Margraff, U., Coenen, A., Jacobs, X., Strivay, M., Lungu, C. & Sondag-Thull, D. (1998) Hemovigilance: clinical tolerance of solvent-detergent treated plasma. Vox Sanguinis, 74, 237-239.
7. Biesert, L. & Suhartono, H. (1998) Solvent/detergent treatment of human plasma - a very robust method for virus inactivation. Validated virus safety of OCTAPLAS. Vox Sanguinis, 74, 207-212.
8. Bowden, R.A. & Sayers, M. (1990) The risk of transmitting cytomegalovirus infection by fresh frozen plasma. Transfusion, 36, 762-763.
9. Brown, F., Meyer, R.F., Law, M., Kramer, E. & Newman, J.F.E. (1998) A universal virus inactivant for decontaminating blood and biopharmaceutical products. Biologicals, 26, 39-47.
10. Burnouf-Radosevich, M., Burnouf, T. & Huart, J.J. (1992) A pasteurized therapeutic plasma. Infusionstherapie, B19B, 91-94.
11. CBER Document no. 0694. (1999) http://www.fda.gov/cber/ recalls.htm.
12. Chandra, S., Cavanaugh, J.E., Lin, C.M., Piette-Jerome, C., Yerram, N., Weeks, R., Flanigan, E. & Feldman, F. (1999) Virus reduction in the preparation of intravenous immune globulin: in vitro experiments. Transfusion, 39, 249-257.
13. Consensus Conference (1985) Fresh-frozen plasma. Indications and risks. Journal of the American Medical Association, 253, 551-553.
14. Contreras, M., Ala, F.A., Greaves, M., Jones, J., Levin, M., Machin, S.J., Morgan, C., Murphy, W. & Napier, J.A.F. British Committee for Standards in Haematology. Blood Transfusion Task Force. (1992) Guidelines for the use of fresh frozen plasma. Transfusion Medicine, 2, 57-63.
15. Corten, L., Dupuis, K., Wiesehahn, G., Cimino, G. & Lin, L. (1996) Sensitivity of Hepatitis C virus to treatment with a novel psoralen and UVA in human platelet concentrates (Abstract). Blood, 88, 526a.
16. Det Norske Veritas (1999) Assessment of the risk of exposure to vCJD infectivity in blood and blood products. Final Report for the Spongiform Encephalopathy Advisory Committee and the Department of Health. Det Norske Veritas Ltd, London.
17. Dodd, R.Y., Moroff, G., Wagner, S., Dabay, M.H., Dorfman, E., George, V., Ribeiro, A., Schumaker, J. & Benade, L.E. (1991) Inactivation of viruses in platelet suspensions that retain their in vitro characteristics: comparison of psoralen-ultraviolet A and merocyanine 540-visible light methods. Transfusion, 31, 483-490.
18. Donegan, E., Lee, H., Operskalski, E.A., Shaw, G.M., Kleinman, S.H., Busch, M.P., Stevens, C.E., Schiff, E.R., Nouricks, M.J., Hollingsworth, C.G., Mosely, J.W. & the Transfusion Safety Study Group. (1994) Transfusion transmission of retroviruses: human T-lymphotropic virus types I and II compared with human immunodeficiency virus (HIV) type 1. Transfusion, 34, 478-483.
19. Evans, G., Llewelyn, C., Luddington, R., Baglin, T.P. & Williamson, L.M. (1999) Solvent/detergent fresh frozen plasma as primary treatment of acute thrombotic thrombocytopenic purpura. Clinical and Laboratory Haematology, 21, 119-123.
20. Evensen, S.A. & Rollag, H. (1993) Solvent/detergent-treated clotting factors and hepatitis A virus seroconversion. Lancet, 341, 971-972.
21. Gerritzen, A., Schneweis, K.E., Brackman, H.H., Oldenburg, J., Hanfland, P., Gerlich, W.H. & Caspari, G. (1992) Acute hepatitis A in haemophiliacs. Lancet, 340, 1231-1232.
22. Goedert, J.J., Kessler, C.M., Aledort, L.M., Biggar, R.J., Andes, W.A., White, G.C.I.I., Drummond, J.E., Vaidya, K., Mann, D.L., Eyster, M.E., Ragni, M.V., Lederman, M.M., Cohen, A.R., Bray, G.L., Rosenberg, P.S., Friedman, R.M., Hilgartner, M.W., Blattner, W.A., Kroner, B. & Gail, M.H. (1989) A prospective study of human immunodeficiency infection and the development of AIDS in subjects with haemophilia. New England Journal of Medicine, 321, 1141-1148.
23. Grass, J.A., Hei, D.J., Metchette, K., Cimino, G.D., Wiesehahn, G.P., Corash, L. & Lin, L. (1998) Inactivation of leukocytes in platelet concentrates by photochemical treatment with psoralen plus UVA. Blood, 91, 2180-2188.
24. Grass, J.A., Wafa, T., Reames, A., Wages, D., Corash, L., Ferrara, J.L.M. & Lin, L. (1999) Prevention of transfusion-associated graftversus-host disease by photochemical treatment. Blood, 93, 3140-3147.
25. Guidelines for Blood Transfusion Services in the United Kingdom. (2000) 4th edn, in press.
26. Hart, H., Reid, K. & Hart, W. (1993) Inactivation of viruses during ultraviolet light treatment of human intravenous immunoglobulin and albumin. Vox Sanguinis, 64, 82-88.
27. Hei, D.J., Grass, J., Lin, L., Corash, L. & Cimino, G. (1999) Elimination of cytokine production in stored platelet concentrate aliquots by photochemical treatment with psoralen plus ultraviolet A light. Transfusion, 39, 239-248.
28. Hellstern, P., Sachse, H., Schwinn, H. & Oberfrank, K. (1992) Manufacture and in vitro characterization of a solvent/detergent-treated human plasma. Vox Sanguinis, 63, 178-185.
29. Hellstern, P., Larbig, E., Walz, G.A., Thürigen, W. & Oberfrank, K. (1993) Prospective study of efficacy and tolerability of solvent/ detergent-treated plasma in intensive care unit patients. Infusion Therapy and Transfusion Medicine, 20, 16-18.
30. Hiemstra, H., Tersmette, M., Vos, A.H.V., Over, H., van Berkel, M.P. & de Bree, H. (1991) Inactivation of human immunodeficiency virus by gamma radiation and its effect on plasma and coagulation factors. Transfusion, 31, 32-39.
31. Hornsey, V.S., Krailadsiri, P., MacDonald, S., Seghatchian, J., Williamson, L.M. & Prowse, C.V. (2000) Coagulation factor content of cryoprecipitate prepared from methylene blue plus light virus-inactivated plasma. British Journal of Haematology, 109, 665-670.
32. Horowitz, B. (1991) Specific inactivation of viruses which can potentially contaminate blood products. Developments in Biological Standards, 75, 43-52.
33. Horowitz, B. & Ben-Hur, E. (1995) Strategies for viral inactivation. Current Opinion in Hematology, 2, 484-492.
34. Horowitz, M.S. & Pehta, J.C. (1998) SD plasma in TTP and coagulation factor deficiencies for which no concentrates are available. Vox Sanguinis, 74, 231-235.
35. Horowitz, B., Bonomo, R., Prince, A.M., Chin, S.N., Brotman, B. & Shulman, R.W. (1992) Solvent/detergent-treated plasma. A virus-inactivated substitute for fresh frozen plasma. Blood, 79, 826-831.
36. Horowitz, B., Prince, A.M., Horowitz, M.S. & Watklevicz, C. (1993) Viral safety of solvent-detergent treated blood products. Developments in Biological Standards, 81, 147-161.
37. Horowitz, B., Lazo, A., Grossberg, H., Page, G., Lippin, A. & Swan, G. (1998) Virus inactivation by solvent/detergent treatment and the manufacture of SD-plasma. Vox Sanguinis, 74, 203-206.
38. Horowitz, B., Page, G., Swan, G., Lazo, A., Gumaer, D., Kapitula, D., Strong, J., Tassello, J., Zhao, J., Gibaja, V. & Abujoub, A. (1999) Hepatitis A virus (HAV) and parvovirus B19 (B19) in donor blood. Transfusion, 39, p116S.
39. Inbal, A., Epstein, O., Blickstein, D., Kornbrot, N., Brenner, B. & Martinowitz, U. (1993) Evaluation of solvent/detergent treated plasma in the management of patients with hereditary and acquired coagulation disorders. Blood Coagulation and Fibrinolysis, 4, 599-604.
40. Keeling, D.M., Luddington, R., Allain, J.P., Lawrie, A.S. & Williamson, L.M. (1997) Cryoprecipitate prepared from plasma virally inactivated by the solvent detergent method. British Journal of Haematology, 96, 194-197.
41. Klein, H.G., Dodd, R.Y., Dzik, W.H., Luban, N.L., Ness, P.M., Pisciotto, P., Schiff, P.D. & Snyder, E.L. (1998) Current status of solvent/detergent-treated frozen plasma. Transfusion, 38, 102-107.
42. Knowles, S. (1995) Preparation of blood components. In: Modern Transfusion Medicine (ed. by D.H. Pamphilon), pp. 25-41. CRC Press, Boca Raton.
43. Lambrecht, B., Mohr, H., Knüver-Hopf, J. & Schmitt, H. (1991) Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light. Vox Sanguinis, 60, 207-213.
44. Lin, L., Cook, D.N., Wiesehahn, G.P., Alfonso, R., Behrman, B., Cimino, G.D., Corten, L., Damonte, P.B., Dikeman, R., Dupuis, K., Fang, Y.M., Hanson, C.V., Hearst, J.E., Lin, C.Y., Londe, H.F., Metchette, K., Nerio, A.T., Pu, J.T., Reames, A., Rheinschmidt, M., Tessman, J., Isaacs, S.T., Wollowitz, S. & Corash, L. (1997) Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light. Transfusion, 37, 423-435.
45. MacGregor, I., Hope, J., Barnard, G., Kirby, L., Drummond, O., Pepper, D., Hornsey, V., Barclay, R., Bessos, H., Turner, M. & Prowse, C. (1999) Application of a time-resolved fluoroimmunoassay for the analysis of normal prion protein in human blood and its components. Vox Sanguinis, 77, 88-96.
46. Mannucci, P.M. (1992) Outbreak of hepatitis A among Italian patients with haemophilia. Lancet, 339, 819.
47. Margolis-Nunno, H., Bardossy, L., Robinson, R., Ben-Hur, E., Horowitz, B. & Blajchman, M.A. (1997) Psoralen-mediated photodecontamination of platelet concentrates: inactivation of cell-free and cell-associated forms of human immunodeficiency virus and assessment of platelet function in vivo. Transfusion, 37, 889-895.
48. Mitra, G., Dobkin, M., Dumas, M., Ng, P., Roldan, G. & Galloway, C. (1994) Hepatitis A viral safety of plasma-derived Factor VIII concentrate Koate-HP. Vox Sanguinis, 67, 80-82.
49. Moake, J., Chintagumpala, M., Turner, N., McPherson, P., Nolasco, L., Steuber, C., Santiago-Borrero, P., Horowitz, M. & Pehta, J. (1994) Solvent/detergent-treated plasma suppresses shear-induced platelet aggregation and prevents episodes of thrombotic thrombocytopenic purpura. Blood, 84, 490-497.
50. Mohr, H., Knuver-Hopf, J., Lambrecht, B., Scheidecker, H. & Schmitt, H. (1992) No evidence for neoantigens in human plasma after photochemical virus inactivation. Annals of Hematology, 65, 224-228.
51. Mohr, H., Bachmann, B., Klein-Struckmeier, A. & Lambrecht, B. (1997) Virus inactivation of blood products by phenothiazine dyes and light. Photochemistry and Photobiology, 65, 441-445.
52. Morel, P., Lin, L., Wiesehahn, G. & Corash, L. (1992) Photochemical inactivation of viruses and bacteriophage in plasma and plasma fractions. Blood Cells, 18, 27-42.
53. Müller-Breitkreutz, K. & Mohr, H. (1998) Hepatitis C. and human immunodeficiency virus RNA degradation by methylene blue/ light treatment of human plasma. Journal of Medical Virology, 56, 239-245.
54. Peerlinck, K. & Vermylen, J. (1993) Acute hepatitis A in patients with haemophilia A. Lancet, 341, 179.
55. Pehta, J.C. (1996) Clinical studies with solvent detergent-treated products. Transfusion Medicine Reviews, X, 303-311.
56. Periera, A. (1999) Cost effectiveness of transfusing virus-inactivated plasma instead of standard plasma. Transfusion, 39, 479-487.
57. Perrotta, P.L., Baril, L., Tead, C., Chapman, J., Dincecco, D., Buchholz, D.H. & Snyder, E.L. (1999) Effects of methylene blue-treated plasma on red cells and stored platelet concentrates. Transfusion, 39, 63-69.
58. Piët, M.P.J., Chin, S., Prince, A.M., Brotman, B., Cundell, A.M. & Horowitz, B. (1990) The use of tri(n-butyl) phosphate detergent mixtures to inactivate hepatitis viruses and human immunodeficiency virus in plasma and plasma's subsequent fractionation. Transfusion, 30, 591-598.
59. Piquet, Y., Janvier, G., Selosse, P., Doutremepuich, C., Jouneau, J., Nicolle, G., Platel, D. & Vezon, G. (1992) Virus inactivation of fresh frozen plasma by a solvent detergent procedure: biological results. Vox Sanguinis, 63, 251-256.
60. Pohl, U. & Mohr, H. (1994) Virus inactivation of plasma by methylene blue/light exposure: clinical experiences. Transfusion Today, 21, 2-3.
61. Pohl, U., Wieding, J.U., Kirchmaier, C.M., Unterhalt, M., Bockhorst, K.G., Mohr, H., Köhler, M., Seifried, E. & Diekamp, U. (1995) Treatment of patients with severe congenital coagulation factor V or XI deficiency with methylene blue virus inactivated fresh frozen plasma (MB-VIP) (Abstract). In: International Society of Blood Transfusion, Fifth Regional (Fourth European) Congress, Venezia, p. 93. SIMTI Servizi s.r.l., Milan.
62. Prince, A.M., Stephan, W., Kotitschke, R. & Brotman, B. (1983) Inactivation of hepatitis B and non-A, non-B viruses by combined use of Tween 80, β-Priopiolactone, and ultraviolet irradiation. Thrombosis and Haemostasis, 50, 534-536.
63. Prodouz, K.N., Fratantoni, J.C., Boone, E.J. & Bonner, R.F. (1987) Use of laser-UV for inactivation of virus in blood products. Blood, 70, 589-592.
64. Prowse, C., Follett, E. & Prince, A. (eds) (1994) Hepatitis a virus transmission by blood products. Vox Sanguinis, 67 (Suppl. 1), 2-85.
65. Rider, J.R., Winter, M.A., Payrat, J.-M., Mathias, J.-M. & Pamphilon, D.H. (1998) Leucocytes can be eliminated from plasma by filtration prior to viral inactivation with methylene blue. Vox Sanguinis, 74, 209-210.
66. Roberts, P.L., Walker, C.P. & Feldman, P.A. (1994) Removal and inactivation of enveloped and non-enveloped viruses during the purification of a high-purity factor IX by metal chelate affinity chromatography. Vox Sanguinis, 67, 69-71.
67. Robinson, S.M., Schwinn, H. & Smith, A. (1992) Clotting factors and hepatitis A (Letter). Lancet, 340, 1465.
68. Rock, G., Shumak, K., Sutton, D., Buskard, N.A. & Nair, R. (1996) Cryosupernatant as replacement fluid for plasma exchange in thrombotic thrombocytopenic purpura. British Journal of Haematology, 94, 383-386.
69. Schots, J. & Steenssens, L. (1994) Blood usage review in a Belgian University hospital. International Journal of Quality and Health Care, 6, 41-45.
70. Simonsen, A.C. & Sorensen, H. (1999) Clinical tolerance of methylene blue virus-inactivated plasma. Vox Sanguinis, 77, 210-217.
71. Sirchia, G., Giovanetti, A.M., McClelland, B. & Frachia, G.N., (eds) (1994) Safe and Good Blood Usage in Surgery (Sanguis). European Commission, Luxembourg.
72. Snyder, A.J., Gottschall, J.L. & Menitove, J.E. (1986) Why is fresh-frozen plasma transfused? Transfusion, 26, 107-112.
73. Snyder, E., Napychank, P., Baril, L. & Pisciotto, P. (1994) Effects of solvent/detergent plasma on red blood cell components. Transfusion, 34, S165.
74. Solheim, B.G., Svennevig, J.L., Mohr, B., Dragsund, M., Noddeland, H., Töllefsrud, S., Brosstad, F., Rollag, H. & Mollnes, T.E. (1993) The use of Octaplas in patients undergoing open heart surgery. In: DIC: Pathogenesis, Diagnosis and Therapy of Disseminated Intravascular Fibrin Formation (ed. by G. Müller-Berghaus), pp. 253-262. Elsevier Science, Amsterdam.
75. Solheim, B.G., Rollag, H., Svennevig, J.L., Arafa, O., Fosse, E. & Bergerud, U. (2000) Viral safety of solvent/detergent treated plasma. Transfusion, 40, 84-90.
76. Temperley, I.J., Cotter, K.P., Walsh, T.J., Power, J. & Hillary, I.B. (1992) Clotting factors and hepatitis A. Lancet, 340, 1466.
77. Thomson, A., Contreras, M. & Knowles, S. (1991) Blood component treatment: a retrospective audit in five major London hospitals. Journal of Clinical Pathology, 44, 734-737.
78. Tocci, L.J., Napychank, P.A., Cable, R.G. & Snyder, E.L. (1993) The effect of solvent/detergent-treated plasma on stored platelet concentrates. Transfusion, 33, 145-149.
79. Tsiquaye, K.N. & Barnard, J. (1993) Chemical disinfection of duck hepatitis B virus: a model for inactivation of infectivity of hepatitis B virus. Journal of Antimicrobial Chemotherapy, 32, 313-323.
80. United Kingdom Haemophilia Centre Directors Organisation. (1997) Guidelines on therapeutic products to treat haemophilia and other hereditary coagulation disorders. Haemophilia, 3, 63-72.
81. Wages, D., Smith, D., Walsh, J., Smyers, J., Chen, C., Moore, C., Jue, C., Davis, K., Metzel, P., Corash, L., Cimino, G., Hei, D., Shafer, S., Wiesehahn, G. & Buchholz, D. (1997) Transfusion of therapeutic doses of virally inactivated fresh frozen plasma in healthy subjects (Abstract). Blood, 90, 409a.
82. Wages, D., Bass, N., Keefe, E., Viele, M., Menozzi, D., Maslow, I., Khalili, M., MacKenzie, M., Porter, L., Smyers, J., Lau, M., Wiesehahn, G. & Corash, L. (1999) Treatment of acquired coagulopathy by transfusion of fresh frozen plasma (FFP) prepared using a novel, single unit photochemical pathogen inactivation (PI) process. Blood, 94 (Suppl. 1), 247a.
83. Wagner, S.J., Cifone, M.A., Murli, H., Dodd, R.Y. & Myhr, B. (1995) Mammalian genotoxicity assessment of methylene blue in plasma: implications for virus inactivation. Transfusion, 35, 407-413.
84. Wagner, S.J., Skripchenko, A., Robinette, D., Foley, J.W. & Cincotta, L. (1998) Factors affecting virus photoinactivation by a series of phenothiazine dyes. Photochemistry and Photobiology, 67, 343-349.
85. Williamson, L.M. & Allain, J.P. (1995) Virally inactivated fresh frozen plasma. Vox Sanguinis, 69, 159-165.
86. Williamson, L.M., Llewelyn, C.A., Fisher, N.C., Allain, J.-P., Bellamy, M.C., Baglin, T.P., Freeman, J., Klinck, J.K., Ala, F.A., Smith, N., Neuberger, J. & Wreghitt, T.G. (1999a) A randomised trial of solvent/detergent and standard fresh frozen plasma in the coagulopathy of liver disease and liver transplantation. Transfusion, 39, 1227-1234.
87. Williamson, L.M., Lowe, S., Love, E., Cohen, H., Solden, K., McClelland, D.B.L., Norfolk, D.R., Revill, J., Barbara, J.A.J., Birrell, D. & Todd, A. (1999b) SHOT Annual Report, 1997-1998. Serious Hazards of Transfusion Group (Manchester), ISBN: O 9532 789 1 3.
88. Zeiler, T., Riess, H., Wittmann, G., Hintz, G., Zimmermann, R., Müller, C., Heuft, H.G. & Huhn, D. (1994) The effect of methylene blue phototreatment on plasma proteins and in vitro coagulation capability of single-donor fresh frozen plasma. Transfusion, 34, 685-689.